Terms: = Pancreatic cancer AND PIK3CA, MGC142161, 5290, ENSG00000121879, P42336, MGC142163, p110-alpha, PI3K AND Diagnosis
72 results:
1. PELI1: key players in the oncogenic characteristics of pancreatic cancer.
Fei X; Zhu C; Liu P; Liu S; Ren L; Lu R; Hou J; Gao Y; Wang X; Pan Y
J Exp Clin Cancer Res; 2024 Mar; 43(1):91. PubMed ID: 38528516
[TBL] [Abstract] [Full Text] [Related]
2. Activation of the pi3k/AKT signaling pathway by ARNTL2 enhances cellular glycolysis and sensitizes pancreatic adenocarcinoma to erlotinib.
Ge W; Wang Y; Quan M; Mao T; Bischof EY; Xu H; Zhang X; Li S; Yue M; Ma J; Yang H; Wang L; Yu Z; Wang L; Cui J
Mol Cancer; 2024 Mar; 23(1):48. PubMed ID: 38459558
[TBL] [Abstract] [Full Text] [Related]
3. NUDT21 interacts with NDUFS2 to activate the pi3k/AKT pathway and promotes pancreatic cancer pathogenesis.
Huang XD; Chen YW; Tian L; Du L; Cheng XC; Lu YX; Lin DD; Xiao FJ
J Cancer Res Clin Oncol; 2024 Jan; 150(1):8. PubMed ID: 38195952
[TBL] [Abstract] [Full Text] [Related]
4. EPYC functions as a novel prognostic biomarker for pancreatic cancer.
Yang Z; Li H; Hao J; Mei H; Qiu M; Wang H; Gao M
Sci Rep; 2024 Jan; 14(1):719. PubMed ID: 38184732
[TBL] [Abstract] [Full Text] [Related]
5. A review of functional pancreatic neuroendocrine tumors: Exploring the molecular pathogenesis, diagnosis and treatment.
Alshareefy Y; Cummins S; Mazzoleni A; Sharma V; Guggilapu S; Leong AWY; Wireko AA
Medicine (Baltimore); 2023 Nov; 102(46):e36094. PubMed ID: 37986400
[TBL] [Abstract] [Full Text] [Related]
6. AUM302, a novel triple kinase PIM/pi3k/mTOR inhibitor, is a potent in vitro pancreatic cancer growth inhibitor.
Ingle K; LaComb JF; Graves LM; Baines AT; Bialkowska AB
PLoS One; 2023; 18(11):e0294065. PubMed ID: 37943821
[TBL] [Abstract] [Full Text] [Related]
7. Mutation Analysis of pancreatic Juice and Plasma for the Detection of pancreatic cancer.
Levink IJM; Jansen MPHM; Azmani Z; van IJcken W; van Marion R; Peppelenbosch MP; Cahen DL; Fuhler GM; Bruno MJ
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37685923
[TBL] [Abstract] [Full Text] [Related]
8. Detecting undetectable - epidemiology, etiology, and diagnosis of carcinoma of unknown primary - systematic review.
Ostojewska J; Wieczorek I; Pachciński O; Zdziennicki W; Burdan F
Folia Med Cracov; 2023 Apr; 63(1):19-37. PubMed ID: 37406274
[TBL] [Abstract] [Full Text] [Related]
9. The Link between Diabetes, pancreatic Tumors, and miRNAs-New Players for diagnosis and Therapy?
Kozłowska M; Śliwińska A
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373398
[TBL] [Abstract] [Full Text] [Related]
10. Predictive ability of pancreatic cyst fluid biomarkers: A systematic review and meta-analysis.
Pflüger MJ; Jamouss KT; Afghani E; Lim SJ; Rodriguez Franco S; Mayo H; Spann M; Wang H; Singhi A; Lennon AM; Wood LD
Pancreatology; 2023 Nov; 23(7):868-877. PubMed ID: 37230894
[TBL] [Abstract] [Full Text] [Related]
11. Emerging roles of long non-coding RNA FTX in human disorders.
Sheykhi-Sabzehpoush M; Ghasemian M; Khojasteh Pour F; Mighani M; Moghanibashi M; Mohammad Jafari R; Zabel M; Dzięgiel P; Farzaneh M; Kempisty B
Clin Transl Oncol; 2023 Oct; 25(10):2812-2831. PubMed ID: 37095425
[TBL] [Abstract] [Full Text] [Related]
12. Robust Acute Pancreatitis Identification and diagnosis: RAPIDx.
Zhu Q; Luo J; Li HP; Ye W; Pan R; Shi KQ; Yang R; Xu H; Li H; Lee LP; Liu F
ACS Nano; 2023 May; 17(9):8564-8574. PubMed ID: 36988967
[TBL] [Abstract] [Full Text] [Related]
13. Crosstalk between circRNAs and the pi3k/AKT and/or MEK/ERK signaling pathways in digestive tract malignancy progression.
Wu C; Huang X; Li M; Wang Z; Zhang Y; Tian B
Future Oncol; 2022 Dec; 18(40):4525-4538. PubMed ID: 36891896
[TBL] [Abstract] [Full Text] [Related]
14. Effect of STK3 on proliferation and apoptosis of pancreatic cancer cells via pi3k/AKT/mTOR pathway.
Chen J; Liu F; Wu J; Yang Y; He J; Wu F; Yang K; Li J; Jiang Z; Jiang Z
Cell Signal; 2023 Jun; 106():110642. PubMed ID: 36871796
[TBL] [Abstract] [Full Text] [Related]
15. The role of microRNA-21 (miR-21) in pathogenesis, diagnosis, and prognosis of gastrointestinal cancers: A review.
Farasati Far B; Vakili K; Fathi M; Yaghoobpoor S; Bhia M; Naimi-Jamal MR
Life Sci; 2023 Mar; 316():121340. PubMed ID: 36586571
[TBL] [Abstract] [Full Text] [Related]
16. Developing and validating a survival prediction model based on blood exosomal ceRNA network in patients with PAAD.
Wang S; Xu L; Zhu K; Zhu H; Zhang D; Wang C; Wang Q
BMC Med Genomics; 2022 Dec; 15(1):260. PubMed ID: 36522691
[TBL] [Abstract] [Full Text] [Related]
17. Comprehensive transcriptomic profiling and mutational landscape of primary gastric linitis plastica.
Liu Z; Hong LL; Zheng JS; Ling ZN; Zhang ZL; Qi YN; Zhang XY; Zhu TY; Wang JL; Han J; Chen XL; Yu QM; Wang S; Li P; Ling ZQ
Gastric Cancer; 2023 Mar; 26(2):203-219. PubMed ID: 36450891
[TBL] [Abstract] [Full Text] [Related]
18. The roles and mechanisms of circular RNAs related to mTOR in cancers.
Cao C; Wang Y; Wu X; Li Z; Guo J; Sun W
J Clin Lab Anal; 2022 Dec; 36(12):e24783. PubMed ID: 36426933
[TBL] [Abstract] [Full Text] [Related]
19. Pancreatoblastoma in Elderly Adults: Report of Two Patients.
Kulak O; Osipov A; Hendifar AE; Nissen NN; Cox BK; Hruban RH; Hutchings DA
Int J Surg Pathol; 2023 Aug; 31(5):772-777. PubMed ID: 36314453
[No Abstract] [Full Text] [Related]
20. HTR1D functions as a key target of HOXA10-AS/miR-340-3p axis to promote the malignant outcome of pancreatic cancer via pi3k-AKT signaling pathway.
Wu W; Li Q; Zhu Z; Li C; Lu P; Zhou X; Huang Y; Liu Y; Wang M; Gong J
Int J Biol Sci; 2022; 18(9):3777-3794. PubMed ID: 35813473
[TBL] [Abstract] [Full Text] [Related]
[Next]
